학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 1,253건 | 목록 1~20
Academic Journal
Takashima Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Akimoto N; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Gastroenterology, Nippon Medical School, Graduate School of Medicine, Tokyo, Japan.; Ugai T; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Bell P; Department of Pathology, Cleveland Clinic, Cleveland, Ohio.; Väyrynen JP; Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.; Hornick JL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Zhong Y; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Ugai S; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Haruki K; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Yao Q; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Matsuda K; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Higashioka M; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Buchanan DD; Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, Australia.; Collaborative Centre for Genomic Cancer Medicine, Victorian Comprehensive Cancer Centre, Parkville, Australia.; Genomic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, Australia.; Phipps AI; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington.; Peters U; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington.; Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Song M; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Chan AT; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Fuchs CS; Genentech, South San Francisco, California.; Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ogino S; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Institute of Science Tokyo, Tokyo, Japan.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Academic Journal
Wesselink E; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.; Thomas CE; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Takashima Y; Department of Medical Oncology, Dana-Farber Cancer Insititute, Boston, Massachusetts.; Mizuno H; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Buchanan DD; Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, Australia.; University of Melbourne Centre for Cancer Research, The University of Melbourne, Parkville, Australia.; Genomic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, Australia.; Qu C; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Hsu L; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Biostatistics, University of Washington, Seattle, Washington.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Ugai S; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Zhong Y; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Huyghe JR; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Thomas S; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Gallinger S; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada.; Grant RC; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Le Marchand L; University of Hawaii Cancer Center, Honolulu, Hawaii.; Masugi Y; Department of Pathology, Tokai University School of Medicine, Isehara, Japan.; van Duijnhoven FJB; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.; Ugai T; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Ogino S; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Tokyo Medical and Dental University (Institute of Science Tokyo), Tokyo, Japan.; Nowak JA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Peters U; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington.; Phipps AI; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE
Academic Journal
Thomas CE; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Takashima Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Wesselink E; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, Netherlands.; Ugai T; Program in Molecular Pathological Epidemiology (MPE), Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States.; Cancer Epidemiology Program, Dana-Farber/Harvard Cancer Center, Boston, MA, United States.; Steinfelder RS; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Buchanan DD; Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia.; University of Melbourne Centre for Cancer Research, The University of Melbourne, Parkville, VIC, Australia.; Genomic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, VIC, Australia.; Qu C; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Hsu L; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Department of Biostatistics, University of Washington, Seattle, WA, United States.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.; Gallinger S; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.; Grant RC; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Huyghe JR; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Thomas SS; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Ogino S; Program in Molecular Pathological Epidemiology (MPE), Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.; Institute of Science Tokyo, Tokyo, Japan.; Phipps AI; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Department of Epidemiology, University of Washington, Seattle, WA, United States.; Nowak JA; Program in Molecular Pathological Epidemiology (MPE), Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, United States.; Peters U; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Department of Epidemiology, University of Washington, Seattle, WA, United States.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Thomas CE; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Takashima Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Buchanan DD; Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, Australia.; University of Melbourne Centre for Cancer Research, The University of Melbourne, Parkville, Australia.; Genomic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, Australia.; Wesselink E; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands.; Qu C; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Hsu L; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Biostatistics, University of Washington, Seattle, Washington.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Gallinger S; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada.; Grant RC; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Huyghe JR; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Thomas S; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Ugai S; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Zhong Y; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Matsuda K; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Ugai T; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Peters U; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington.; Ogino S; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Institute of Science Tokyo, Tokyo, Japan.; Nowak JA; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Phipps AI; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE
Academic Journal
Ugai S; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Yao Q; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Takashima Y; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical, Boston, Massachusetts, USA.; Zhong Y; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Matsuda K; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Kawamura H; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Fukushima Medical University, Fukushima, Japan.; Imamura Y; Department of Esophageal Surgery, The Cancer Institute Hospital of the Japanese Foundation of Cancer Research, Tokyo, Japan.; Okadome K; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Mima K; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.; Arima K; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.; Kosumi K; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.; Song M; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical, Boston, Massachusetts, USA.; Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Nowak JA; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical, Boston, Massachusetts, USA.; Ugai T; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Ogino S; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Cancer Immunology Program, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, USA.; Tokyo Medical and Dental University (Institute of Science Tokyo), Tokyo, Japan.
Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE
Academic Journal
Lau MC; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A STAR), Singapore, Republic of Singapore.; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A STAR), Singapore, Republic of Singapore.; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Borowsky J; Conjoint Gastroenterology Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Väyrynen JP; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.; Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.; Haruki K; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.; Zhao M; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.; Gu S; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; da Silva A; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Ugai T; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Arima K; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Nguyen MN; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A STAR), Singapore, Republic of Singapore.; Takashima Y; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.; Yeong J; Division of Pathology, Singapore General Hospital, Singapore, Republic of Singapore.; Integrative Biology for Theranostics, Institute of Molecular Cell Biology, Agency of Science, Technology and Research (A STAR), Singapore, Republic of Singapore.; Tai D; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Republic of Singapore.; Duke NUS Medical School, Singapore, Republic of Singapore.; Hamada T; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Lennerz JK; BostonGene; Waltham, Boston, Massachusetts, United States of America.; Fuchs CS; Genentech, South San Francisco, California, United States of America.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.; Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.; Ogino S; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.; Cancer Immunology and Cancer Epidemiology Programs, Dana-Farber Harvard Cancer Center, Boston, Massachusetts, United States of America.; Nowak JA; Department of Pathology, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Ugai, T.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어